United States · FDA National Drug Code directory
Gefitinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67184-0531_8aa73f33-2813-4dfa-939f-e4291081449a
- Product NDC
- 67184-0531
- Form
- TABLET, COATED
- Composition / generic term
- Gefitinib
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230213
- Source listing expiry
- 20261231
Source-listed ingredients
- GEFITINIB — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, COATED in 1 BOTTLE (67184-0531-1) · 67184-0531-1
- 500 TABLET, COATED in 1 BOTTLE (67184-0531-2) · 67184-0531-2
- 3 BLISTER PACK in 1 CARTON (67184-0531-3) / 10 TABLET, COATED in 1 BLISTER PACK · 67184-0531-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →